| Primary information |
|---|
| ID | 1104 |
| Peptide Name | HIV-1 soluble gp41 (sgp41) (539-684) |
| Sequence | VQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNHTTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIKI |
| Length | 146 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Nature | Protein Derived |
| Source of Origin | HIV-1 isolate IIIB |
| Target | NA |
| Mechanism of Action | Enhances MHC class I expression |
| In vitro/In vivo | In vitro |
| Cell Line | Human H9, Jurkat, Raji, Daudi. U937 and HEF cell lines |
| Inhibition Concentartion | NA |
| In vivo Model | NA |
| Assay | NA |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | 9373217 |
| Year of Publication | 1997 |
| 3-D Structure |  View in Jmol or Download Structure |
